原发性中枢神经系统移植后淋巴组织增生性疾病 - Suppr | 超能文献

Primary central nervous system post-transplantation lymphoproliferative disorder.

作者信息

Dierickx Daan, Tousseyn Thomas, Verhoef Gregor

出版信息

Cancer. 2010 Jul 15;116(14):3521; author reply 3521-2. doi: 10.1002/cncr.25340.

DOI:10.1002/cncr.25340

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Primary central nervous system post-transplantation lymphoproliferative disorder.原发性中枢神经系统移植后淋巴组织增生性疾病

Cancer. 2010 Jul 15;116(14):3521; author reply 3521-2. doi: 10.1002/cncr.25340.

2

Pathology of central nervous system posttransplant lymphoproliferative disorders: lessons from pediatric autopsies.移植后中枢神经系统淋巴组织增生性疾病的病理学：来自儿科尸检的经验教训。

Pediatr Dev Pathol. 2013 Mar-Apr;16(2):67-73. doi: 10.2350/12-01-1148-OA.1. Epub 2013 Jan 3.

3

Post-transplant lymphoproliferative disorder: the significance of central nervous system disease.

Pediatr Transplant. 2012 Sep;16(6):528-9. doi: 10.1111/j.1399-3046.2012.01743.x. Epub 2012 Jun 21.

4

Post-transplant lymphoproliferative disorders.

S Afr J Surg. 1998 Feb;36(1):4, 6, 8-9.

5

Molecular genetic analysis of post-transplant lymphoproliferative disorders.移植后淋巴细胞增殖性疾病的分子遗传学分析

Hematol Oncol Clin North Am. 1993 Apr;7(2):447-65.

6

Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report.原发性中枢神经系统移植后淋巴组织增生性疾病：国际原发性中枢神经系统淋巴瘤协作组报告。

Cancer. 2010 Feb 15;116(4):863-70. doi: 10.1002/cncr.24834.

7

CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.中枢神经系统或骨髓受累作为实体器官移植后儿童移植后淋巴细胞增生性疾病生存不良的危险因素。

J Clin Oncol. 2007 Nov 1;25(31):4902-8. doi: 10.1200/JCO.2006.10.2392.

8

T-cell post-transplantation lymphoproliferative disorder, a rare and challenging late complication of solid organ transplantation.T细胞移植后淋巴增殖性疾病，一种实体器官移植罕见且具有挑战性的晚期并发症。

Pediatr Transplant. 2008 Sep;12(6):617-8. doi: 10.1111/j.1399-3046.2008.00915.x. Epub 2008 Mar 12.

9

Nonimmune complications after transplantation.移植后的非免疫并发症。

Pediatr Clin North Am. 2010 Apr;57(2):505-21, table of contents. doi: 10.1016/j.pcl.2010.01.008.

10

Infectious complications of immunosuppressive medications in organ transplant recipients.

Pediatr Infect Dis J. 2007 May;26(5):443-4. doi: 10.1097/01.inf.0000261010.28610.88.

引用本文的文献

1

Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma Alliance.PET与利妥昔单抗时代弥漫性大B细胞淋巴瘤移植后淋巴细胞增殖性疾病的管理与转归：一项来自澳大拉西亚淋巴瘤联盟的多中心研究

Hemasphere. 2021 Oct 11;5(11):e648. doi: 10.1097/HS9.0000000000000648. eCollection 2021 Nov.

2

In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy.深入剖析中枢神经系统淋巴瘤的肿瘤微环境，揭示免疫检查点治疗的意义。

Cancer Immunol Immunother. 2020 Sep;69(9):1751-1766. doi: 10.1007/s00262-020-02575-y. Epub 2020 Apr 25.

3

Posttransplant lymphoproliferative disease after pediatric solid organ transplantation.小儿实体器官移植后的移植后淋巴细胞增生性疾病

Clin Dev Immunol. 2013;2013:814973. doi: 10.1155/2013/814973. Epub 2013 Sep 24.